This site is intended for health professionals only
Tuesday 23 October 2018
Share |

Once-daily treatment option for people with type 2 diabetes and moderate CKD in the UK

A once-daily injection has been approved for adults with type 2 diabetes and moderate renal impairment
  • Moderate chronic kidney disease affects up to 40% of all people with type 2 diabetes in the UK, which is approximately one million people (1,2).
  • Type 2 diabetes costs the NHS a total of £21.8 billion in 2010/2011, with the complications of chronic kidney disease accounting for an estimated £753.8 million. These figures are predicted to rise to £35.6 billion for type 2 diabetes and £1.3 billion for kidney disease in people with type 2 diabetes by 2035/36 (3).

Ads by Google